Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics.
For patients undergoing intraperitoneal ("belly bath") chemotherapy, it is useful to verify the distribution of infusion fluid. For this reason, 10 patients were examined by computed tomography (CT) after intraperitoneal instillation of dialysate mixed with water soluble contrast material. The extent of intraperitoneal distribution was assessed, and in two patients filling defects, presumably representing tumor, were identified.
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001202:Ascitic Fluid; D003287:Contrast Media / Q000008:administration & dosage*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007274:Injections, Intraperitoneal; D008545:Melanoma / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010534:Peritoneal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy; D010537:Peritoneum / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D003287:Contrast Media; D005472:Fluorouracil; D008727:Methotrexate